Literature DB >> 19735658

Partial protective responses induced by a recombinant cysteine proteinase from Leishmania (Leishmania) amazonensis in a murine model of cutaneous leishmaniasis.

Carlos Eduardo Cardoso Fedeli1, Josie Haydée Lima Ferreira, Juliana Sekeres Mussalem, Ieda Maria Longo-Maugéri, Luciana Girotto Gentil, Márcia Regina Machado dos Santos, Simone Katz, Clara Lúcia Barbiéri.   

Abstract

A 500 bp fragment encoding an isoform of cysteine proteinase from Leishmania (Leishmania) amazonensis was subcloned and expressed in the pHis vector, resulting in a recombinant protein of 24 kDa, rLacys24. In Western blots of L. (L.) amazonensis extracts, antibodies directed to rLacys24 recognized a cysteine proteinase isoform of 30 kDa. Analysis by fluorescence-activated cell sorter showed a significantly higher expression of CD8(+) lymphocytes in animals immunized with rLacys24 plus CFA, whereas a low expression of CD4(+) lymphocytes was observed in these animals. The cytotoxicity of lymphocytes isolated from mice immunized with rLacys24 plus CFA on L. (L.) amazonensis-infected macrophages was significantly higher than that observed in the presence of lymphocytes from control animals. Immunization of BALB/c mice with rLacys24 plus CFA resulted in a low but significant decrease of foot lesions after challenge with L. (L.) amazonensis compared to those exhibited by control mice. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19735658     DOI: 10.1016/j.exppara.2009.09.003

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  5 in total

1.  Vaccines for leishmaniasis and the implications of their development for American tegumentary leishmaniasis.

Authors:  Beatriz Coutinho De Oliveira; Malcolm S Duthie; Valéria Rêgo Alves Pereira
Journal:  Hum Vaccin Immunother       Date:  2019-11-11       Impact factor: 3.452

2.  Treatment of Leishmania (Leishmania) Amazonensis-Infected Mice with a Combination of a Palladacycle Complex and Heat-Killed Propionibacterium acnes Triggers Protective Cellular Immune Responses.

Authors:  Carolina S Paladi; Danielle A M da Silva; Priscila D Motta; Daniel M Garcia; Daniela Teixeira; Ieda M Longo-Maugéri; Simone Katz; Clara L Barbiéri
Journal:  Front Microbiol       Date:  2017-03-06       Impact factor: 5.640

3.  Immunoinformatics Features Linked to Leishmania Vaccine Development: Data Integration of Experimental and In Silico Studies.

Authors:  Rory C F Brito; Frederico G Guimarães; João P L Velloso; Rodrigo Corrêa-Oliveira; Jeronimo C Ruiz; Alexandre B Reis; Daniela M Resende
Journal:  Int J Mol Sci       Date:  2017-02-10       Impact factor: 5.923

4.  Leishmanicidal and Immunomodulatory Activities of the Palladacycle Complex DPPE 1.1, a Potential Candidate for Treatment of Cutaneous Leishmaniasis.

Authors:  Isabela B Dos Santos; Danielle A M da Silva; Fabiana A C R Paz; Daniel M Garcia; Adriana K Carmona; Daniela Teixeira; Ieda M Longo-Maugéri; Simone Katz; Clara L Barbiéri
Journal:  Front Microbiol       Date:  2018-07-03       Impact factor: 5.640

5.  Protective Cellular Immune Response Induction for Cutaneous Leishmaniasis by a New Immunochemotherapy Schedule.

Authors:  Danielle A M da Silva; Fabiana R Santana; Simone Katz; Daniel M Garcia; Daniela Teixeira; Ieda M Longo-Maugéri; Clara L Barbiéri
Journal:  Front Immunol       Date:  2020-03-03       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.